Jun 3, 2022 7:00 am EDT NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory
May 10, 2022 2:00 am EDT NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting
May 9, 2022 7:00 am EDT NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
Apr 25, 2022 7:00 am EDT NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay
Apr 11, 2022 10:00 am EDT NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
Apr 11, 2022 7:00 am EDT NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
Apr 8, 2022 4:05 pm EDT NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
